Description

Hydroxyethyl Starch

Hydroxyethyl Starch (HES) is a nonionic, modified starch polymer used in pharmaceutical, biomedical, analytical, and specialty formulation programs where controlled molecular characteristics, aqueous compatibility, viscosity, and material consistency are important. Hydroxyethyl Starch is a general material class rather than a single discrete molecular species and is commonly characterized according to average molecular weight, molar substitution, concentration, and substitution pattern. Hydroxyethyl Starch is a pharmaceutical product also known as Hetastarch, a blood volume expander. Hydroxyethyl Starch is
• A nonionic Hydroxyethylated Starch derivative
• A polymeric material characterized by molecular weight and molar substitution
• Suitable for pharmaceutical research, biomedical development, analytical work, and specialty formulation programs
• Functional properties depend on molecular weight, degree of substitution, concentration, and processing history
• Requires careful control of identity, molecular characteristics, purity, and residual processing materials
• Supported by technical documentation for supplier qualification and material characterization
Hydroxyethyl Starch is produced through chemical modification of starch with Hydroxyethyl groups. This modification changes the parent starch polymer’s aqueous behavior, enzymatic degradation characteristics, and physicochemical properties. Because Hydroxyethyl Starch encompasses a family of related polymers, materials are frequently differentiated using values such as 130/0.4, where the first value describes average molecular weight and the second describes molar substitution. These characteristics can significantly influence viscosity, persistence, solution behavior, and performance.
The material may be evaluated in polymer research, drug-delivery studies, formulation development, analytical methods, biomedical research, and other controlled applications where a modified polysaccharide with defined solution properties is required. Hydroxyethyl Starch has also historically been used in intravenous colloid solutions as a plasma volume expander. However, the regulatory and safety status of intravenous Hydroxyethyl Starch products requires particular attention and should not be generalized to other research or material applications.
For companies looking to buy Hydroxyethyl Starch, supplier qualification should extend beyond the general material name. A qualified Hydroxyethyl Starch supplier should provide information regarding botanical or starch source where applicable, average molecular weight, molecular-weight distribution, molar substitution, substitution pattern, viscosity, appearance, moisture content, residual processing materials, microbial quality, elemental impurities, and storage conditions. Customers should confirm the exact grade required before purchase because differences in molecular weight and substitution can materially affect polymer behavior.
CarboMer offers high purity Hydroxyethyl Starch with a range of molecular weights and substitution levels. CarboMer approaches Hydroxyethyl Starch sourcing with a regulation-first and manufacturing-centered perspective. Research and development teams benefit from a supplier capable of supporting polymer characterization, solution preparation, rheological evaluation, formulation screening, and scale-up planning. Quality teams require clearly defined specifications and traceable batch documentation. Procurement professionals need confidence that the molecular and functional characteristics qualified during development can be maintained across subsequent purchases.
When customers purchase Hydroxyethyl Starch for pharmaceutical or biomedical research, the proposed application should be evaluated independently from historical or approved uses of Hydroxyethyl Starch infusion products. In the United States, the Food and Drug Administration requires boxed safety warnings for Hydroxyethyl Starch products used for intravascular volume replacement because of risks including mortality, kidney injury, and excess bleeding. In Europe, regulators have also taken significant action regarding Hydroxyethyl Starch solutions for infusion, including suspension of marketing authorizations because of serious safety concerns in certain patient populations.
These regulatory actions apply specifically to Hydroxyethyl Starch medicinal products used for infusion and should not be interpreted as establishing the regulatory status of every Hydroxyethyl Starch material or research application. At the same time, they make it especially important that the selected grade, intended route of use, regulatory pathway, and supporting safety information be reviewed before pharmaceutical or biomedical development proceeds.
The material is supported by standard technical documentation, including a Certificate of Analysis, Safety Data Sheet, and related product information where applicable. Available characterization may include average molecular weight, molecular-weight distribution, molar substitution, viscosity, moisture, identity, residual processing materials, microbiological specifications, storage conditions, and retest information. Exact acceptance criteria should be confirmed for the individual grade before ordering.
Hydroxyethyl Starch should be handled by trained personnel using laboratory or manufacturing controls appropriate to the selected grade and intended application. Powder handling should minimize contamination, uncontrolled moisture exposure, and airborne particulate generation. When preparing aqueous solutions, mixing conditions, polymer concentration, hydration time, temperature, and viscosity should be controlled to support reproducible performance.
The material is packaged in appropriate containers selected to protect product quality from moisture, contamination, and environmental exposure during storage and transportation. Packaging formats, molecular-weight options, minimum order quantities, availability, and lead times may be discussed according to analytical, research, formulation-development, and qualified manufacturing requirements.
As with all CarboMer products, customers receive responsive technical communication and documentation support intended to advance material qualification, polymer characterization, formulation development, scale-up, and long-term supply planning.